Skip to main content
. 2022 Jan 18;66(1):e01879-21. doi: 10.1128/AAC.01879-21

TABLE 3.

Correlational analysis of planktonic phage susceptibility and phage susceptibilitya

Drug No. of drug-susceptible isolates No. of drug intermediate isolates No. of drug-resistant isolates Phage
ATCC 27698-B1
ATCC 27695-B1
ATCC 27704-B1
ATCC 11988-B1
ATCC 27703-B1
ATCC 23360-B1
ATCC 19685-B1
S R P S R P S R P S R P S R P S R P S R P
Oxacillin 75 NA 38 25 88 1.000 19 94 0.289 7 106 1.000 54 59 0.017 9 104 0.268 73 40 1.000 82 31 0.657
Clindamycin 77 NA 35 24 88 0.466 19 93 0.417 7 105 1.000 53 59 0.315 9 103 0.718 72 40 1.000 81 31 0.649
Rifampin 111 NA 2 25 88 0.395 19 94 1.000 7 106 1.000 54 59 0.497 9 104 1.000 73 40 1.000 82 31 1.000
Daptomycin 56 NA 0 15 41 1.000 10 46 1.000 5 51 1.000 25 31 1.000 3 53 1.000 34 22 1.000 38 18 1.000
Levofloxacin 46 33 34 25 88 0.522 19 94 0.412 7 106 1.000 54 59 0.426 9 104 0.342 73 40 0.527 82 31 0.803
Linezolid 34 NA 0 7 27 1.000 4 30 1.000 3 31 1.000 23 11 1.000 4 30 1.000 26 8 1.000 28 6 1.000
a

The Fisher’s exact test was used to interrogate the relationship between planktonic phage susceptibility and susceptibility to antibiotics shown, α = 0.05. NA = not applicable, S = susceptible, R = resistant.